# OnCo record paper-krystal-12-plain-language-summary-future-oncol-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-krystal-12-plain-language-summary-future-oncol-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-krystal-12-plain-language-summary-future-oncol-2026" ;
  schema:name "KRYSTAL-12 plain language summary: adagrasib for non-small-cell lung cancer with KRAS G12C mutations"@en ;
  schema:description "A plain-language account of the KRYSTAL-12 trial, written for patients and carers, explaining how adagrasib compared with docetaxel chemotherapy in previously treated KRAS G12C lung cancer."@en ;
  schema:url <https://onco.cc/key-papers/paper-krystal-12-plain-language-summary-future-oncol-2026/> ;
  schema:dateModified "2026-09-21"^^xsd:date ;
  schema:citation <https://doi.org/10.1080/14796694.2026.2719409>, <https://pubmed.ncbi.nlm.nih.gov/42745627/>, <https://clinicaltrials.gov/study/NCT04685135> ;
  schema:sameAs <https://doi.org/10.1080/14796694.2026.2719409> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Barlesi F, Yao W, Duruisseaux M, et al." ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/kras-g12c-nsclc/> ;
  onco:targets <https://onco.cc/targets/kras/> ;
  onco:drugs <https://onco.cc/drugs/adagrasib/> ;
  onco:companies <https://onco.cc/companies/bms/> ;
  onco:trials <https://onco.cc/trials/krystal-12/> ;
  onco:people <https://onco.cc/people/fabrice-barlesi/>, <https://onco.cc/people/lu-shun/>, <https://onco.cc/people/martin-reck/>, <https://onco.cc/people/tony-mok/> ;
  onco:journals <https://onco.cc/journals/future-oncology/> .